This lecture provides a comprehensive overview of benign tumors found in the oral cavity, emphasizing clinical diagnosis, cellular pathology, and the management of odontogenic neoplasms. The discussion begins with the crucial steps of clinical examination—inspection, palpation, and exclusion of malignancy—and then details the histological differences between mobile and stable oral mucosa. A significant portion covers cellular responses to stress, distinguishing between reversible injuries (hydropic swelling) and persistent stress adaptations (atrophy, hypertrophy, metaplasia, and dysplasia), noting the neoplastic potential of metaplasia. The lecture highlights odontogenic tumors as a major focus in maxillofacial surgery, outlining their WHO 2017 classification (epithelial, mesenchymal, mixed), clinical presentation (often asymptomatic or presenting as tooth displacement), and definitive treatment through surgical resection. The necessity of thorough pre-operative imaging (CT/CBCT) to prevent damage to associated structures, such as the alveolar nerve, is stressed, alongside the importance of histological typing and long-term follow-up due to recurrence risk.
Benign Tumors of the Oral Cavity: Clinical Signs, Cellular Pathology, and Odontogenic Neoplasms
0:09 Clinical Assessment and Malignancy Exclusion: The initial clinical approach involves visual inspection, palpation ("hypocratic instruments," 0:52) to assess quality, and crucially, ruling out any malignancy. Benign tumors often present as well-circumscribed swellings without ulceration.
2:24 Oral Mucosa Classification: The oral cavity contains local labile (mobile) mucosa (lip, cheek, floor of mouth) and local stable mucosa (palate, alveolar ridges). Stable mucosa is characterized by deep epithelial regions and orthokeratotic keratin layers, necessary for rigid structure around teeth.
4:06 Etiology and Differential Diagnosis: Potential causes of oral tumors are diverse, including vascular entities, inflammation, trauma, metabolic/degenerative issues, and neoplasms (benign or malignant).
11:49 Reversible Cell Injury: Hydropic swelling, a form of reversible cell injury, can be caused by heat, cold, chemical/biological toxins, infections (viral, fungal), or ischemia. Pathologically, it involves large, pale cytoplasm and impairment of the ATP-dependent sodium-potassium pump.
15:14 Cellular Adaptations to Stress: Persistent stress leads to cellular adaptations: Hypertrophy (increased cell size/function), Hyperplasia (increased cell number), Atrophy (decrease in size/function), Metaplasia (conversion of one cell type to another, carrying a neoplastic transformation capacity, 20:19), and Dysplasia (alteration in size/shape/arrangement of cellular components, 20:43).
23:51 Benign vs. Malignant Tumors: Benign tumors are non-penetrative, do not invade adjacent tissue borders, and do not metastasize. They are generally more differentiated and less lethal than malignant tumors.
35:50 Focus on Odontogenic Neoplasms: These tumors originate from the apparatus responsible for tooth development (dental placode through the bell stage) and are a critical area in maxillofacial pathology.
37:36 Odontogenic Symptoms and Diagnosis: Symptoms are often subtle or absent (no pain). Common clinical signs include non-painful swelling, tooth displacement, and delayed tooth eruption. Diagnosis relies on clinical examination, advanced imaging (CT/CBCT/MRI), and mandatory histological typing (39:50).
40:02 Treatment and Classification: The treatment for almost all benign oral tumors is surgical resection (40:07). The WHO 2017 classification organizes odontogenic tumors into three groups: Epithelial, Mesenchymal, and Mixed.
Ameloblastoma: Most common epithelial odontogenic tumor (18% overall). It behaves aggressively locally but does not metastasize (44:02, 54:28).
Odontoma (Mixed Type): Very common; a mixture of epithelial and mesenchymal tissue, often showing chaotic order of enamel and dentine (43:19).
Odontogenic Myxoma: Often multi-loculated with sharp borders (46:45).
49:01 Critical Surgical Consideration: For slow-growing bone tumors, nerves (e.g., alveolar nerve) have time to adapt. Pre-operative planning is vital to drill out and free the nerve before complete tumor resection to prevent nerve damage.
59:59 Follow-up and Recurrence: Surgery must ensure complete removal. Follow-up is essential, as some benign tumors (e.g., Calcifying Epithelial Odontogenic Tumors) have a higher rate of recurrence (59:04).
1:01:23 Q&A - Post-Resection Implants: The possibility of post-resection implant placement depends entirely on individual case study, considering factors like bone recovery and the risk of pathological fracture in areas of very thin or damaged bone.